ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Cox Comm CL A SC23

Cox Comm CL A SC23 (COX)

0.00
0.00
(0.00%)
Cerrado 01 Diciembre 3:00PM
0.00
0.00
(0.00%)
Fuera de horario: -

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Estadísticas y detalles clave

Último Precio
-
Postura de Compra
-
Postura de Venta
-
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.00 Rango de 52 semanas 0.00
Precio Anterior
-
Precio de Apertura
-
Hora
Última hora de negociación
Volumen promedio (3 m)
-
Volumen financiero
-
Precio Promedio Ponderado
-

COX Últimas noticias

Nicox first quarter 2015 financial and business update

SOPHIA ANTIPOLIS, France, April 17, 2015 (GLOBE NEWSWIRE) -- Nicox S.A. (Euronext Paris: FR0000074130, COX), the international ophthalmic company, today reported its first quarter 2015 revenues...

Nicox 2014 Financial Results and Business Update

A year of strategic progress: Positive phase 3 results for Vesneo(TM) (Bausch + Lomb); NDA submission on track for Q2 2015 Significant strengthening of ophthalmic therapeutics...

Nicox receives Orphan Drug Designation from FDA for naproxcinod in Duchenne Muscular Dystrophy

SOPHIA ANTIPOLIS, France, March 19, 2015 (GLOBE NEWSWIRE) -- Nicox S.A. (Euronext Paris: COX) today announced that the United States Food and Drug Administration (FDA) has granted Orphan Drug...

Nicox signs exclusive license agreement with InSite Vision for AzaSite(R) and BromSite(TM) in Europe

InSite grants Nicox exclusive license for AzaSite® (1% azithromycin), BromSite(TM) (0.075% bromfenac) and AzaSite Xtra(TM) (2% azithromycin) in Europe, Middle East and...

Nicox holds successful pre-NDA meeting with FDA on AC-170 clinical package

SOPHIA ANTIPOLIS, France, Jan. 26, 2015 (GLOBE NEWSWIRE) -- Nicox S.A. (NYSE Euronext Paris: COX), the international ophthalmic company, today announced that it has held a positive pre-New Drug...

Nicox gains expanded North American rights for Sjo(TM) from Immco Diagnostics

Nicox gains expanded North American rights for Sjö(TM) from Immco Diagnostics Nicox acquires extension of rights to market Sjö(TM) to all healthcare practitioners in North...

Nicox focuses US operations on national launches of Sjo(TM) and RetnaGene(TM) and restructures RPS(R) licensing agreement

Nicox to focus US marketing resources on national roll-out of Sjö(TM) and launch of RetnaGene(TM) Rapid Pathogen Screening (RPS®) partnership for AdenoPlus® and two other...

Nicox to acquire Aciex Therapeutics, Inc.

Significant step forward in Nicox's strategy of creating an international ophthalmic company built around therapeutics and diagnostics Aciex brings a near-term pipeline of ophthalmic...

Nicox launches commercial operations in Germany

SOPHIA ANTIPOLIS, France, June 30, 2014 (GLOBE NEWSWIRE) -- Nicox S.A. (NYSE Euronext Paris: COX), the international ophthalmic company, today announced the launch of its German operations. Nicox...

Nicox and Sequenom announce the launch of expanded access to RetnaGene(TM) test portfolio in the U.S.

SOPHIA ANTIPOLIS, France and SAN DIEGO, June 19, 2014 (GLOBE NEWSWIRE) -- Nicox and Sequenom announce the launch of expanded access to RetnaGene(TM) test portfolio in the U.S. June 19...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
PERFPerfect Corp
US$ 2.61
(36.65%)
400.53k
SOSSOS Limited
US$ 12.40
(24.87%)
1.45M
ACHRArcher Aviation Inc
US$ 9.57
(18.44%)
60.5M
EVTLVertical Aerospace Ltd
US$ 10.10
(16.23%)
454.72k
NRDYNerdy Inc
US$ 1.58
(14.49%)
3.46M
ASAISendas Distribuidora SA
US$ 5.26
(-16.24%)
1.52M
AZULAzul SA
US$ 2.35
(-9.96%)
2.04M
CSANCosan SA
US$ 6.61
(-9.70%)
1.89M
SMRTSmartRent Inc
US$ 1.77
(-9.69%)
575.18k
ATIPATI Physical Therapy Inc
US$ 1.53
(-8.38%)
34.36k
BBDBanco Bradesco SA
US$ 2.13
(-5.75%)
62.17M
ACHRArcher Aviation Inc
US$ 9.57
(18.44%)
60.37M
NUNu Holdings Ltd
US$ 12.53
(-7.39%)
58.04M
QBTSD Wave Quantum Inc
US$ 3.02
(10.22%)
32.82M
VALEVale SA
US$ 9.86
(-0.10%)
28.74M
axelvento axelvento 1 minuto hace
Cytokine-overexpressing dendritic cells for cancer immunotherapy:

https://www.nature.com/articles/s12276-024-01353-5
NWBO
arizona1 arizona1 2 minutos hace
I've asked three MAGAS what state they live in and they've all been too embarrassed to answer WTF is up with that?

Olives
Lime Time
dbergh

Meanwhile, Nick Bosa is having his MAGAt comeuppance. #SoSad

Nick Bosa Injury Karma

N
weedtrader420 weedtrader420 3 minutos hace
XRP did it. #3🪙 Money For Nothing, Love it 😊👍
XRPUSD
VVVVVV VVVVVV 6 minutos hace
My sorry, I couldn’t resist but, this has been debunked several times. This section of the letter, is part of VPLM’s exhibit A, if I’m not mistaken.

I would imagine, the upcoming pretrial conference and trials, which would include the ‘606 RBR with Amazon, would be considered “upcomi
VPLM
rx7171 rx7171 7 minutos hace
In looking at the company page showing planned and under way trials it shows Fragile-X as entering in a Phase 3 trial.
Did I miss a pr on this?

https://www.anavex.com/therapeutic-candidates
AVXL
AKATITUS AKATITUS 7 minutos hace
Yeah I learned my lesson
If you want to daytrade some always go light if you believe in the future of the company
Done it many times and cl$k was my last lesson.
When they blow nobody will know
So holding is the best option or playing very small if one can time it.
K
blackhawks blackhawks 8 minutos hace
This one.....

[yt]KnHw_1h0-fE[/yt]
mrfence mrfence 8 minutos hace
Section 8 is how you were militarily discharged.
FNMA
tothe tothe 8 minutos hace
GDVM Weekly charts: Q-3 catalyst in effect, wash selling and revenue surprise.
* A brief on chart Indicators
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=146368673
chart & TA post thread

~~~ Q-3
https://www.otcmarkets.com/otcapi/company/
GDVM
Ecomike Ecomike 8 minutos hace
It is already too late for your clown parade to cover. Time to pucker up shorty
CNNA
delerious1 delerious1 9 minutos hace
You have to admit....this is kinda fun
XRPUSD
weedtrader420 weedtrader420 9 minutos hace
XRP JUKE BOX HERO🤩🎸
XRPUSD
ducci1 ducci1 11 minutos hace
Pivot Calcs: SPX Pivot--6026----R1--6049----R2--6067----S1--6008----S2--5985-----SPY Pivot--602----R1--603----R2--604----S1--600----S2--598-----VIX Pivot--13.71 !!LOL!!
SPY
ORCA ORCA 13 minutos hace
OLI CRAP.THIS POS REALLY FELL OFF THE CLIFF.AND I WANTED TO LOAD UP SOMETIME AGO.LIKE LOAD UP .03 TO .04.I WOULD HAVE LOST MY SHIRT.I JUST LOOKED AT IT AGAIN.
OMID
crazy horse 0 crazy horse 0 14 minutos hace
No charges filed yet so nothing to Pardon


Are we going to see Justice Dept pardens, FBI pardens, Congressional pardens, Military pardens...
Will we be able to pursue justice, or will all the guilty get a Presidential do-over?
spectrader82 spectrader82 15 minutos hace
Are the courts functional AT ALL?
WNFT
Lonewolf1 Lonewolf1 15 minutos hace
Sell and move on.

Very simple….
CGAC
blackhawks blackhawks 16 minutos hace
Check Trump's latest cabinet appointments, as well as his past nepotism job appointments, before gloating over your video.
crazy horse 0 crazy horse 0 16 minutos hace
BUSH, Clinton, Regan. Obummer all have had wars not only Criminal Biden. Cheney, Graham two of the worst My Country is all I care about !!!

the Abraham Accords worked for the short time 45 was president, until Biden stole the election a started these wars all over the planet....my ho
Hoghead7 Hoghead7 17 minutos hace
I strongly advise reading this from FCE rep in Europe!

"Prior to joining FuelCell Energy in 2021, Miserocchi worked for six years at E.ON as head segment sales data center & telecom in Europe. He also served as key account manager at Vertiv for nine years. Miserocchi also gained exper
FCEL
ORCA ORCA 17 minutos hace
DID THIS POS REALLY GO DOWN TO .005S???
FAGI
weedtrader420 weedtrader420 18 minutos hace
XRP ✖️🪙🪙SEVEN BRIDGES ROAD
XRPUSD
catdaddy catdaddy 18 minutos hace
You tried to have the board believe the class action suit had an 83% chance of success. Tell us how it stands currently!
AVXL
ORCA ORCA 19 minutos hace
IT LOOKS LIKE THEY WANT TO RUN HER.WATCHING.
SAML

Su Consulta Reciente

Delayed Upgrade Clock